This study aims to investigate short-term outcomes following the use of two femoral stems used during Total Hip arthoplasty: the Fitmore Femoral stem and the M/L Taper Femoral stem.

Inclusion Criteria:

• Patient signed an IRB, study specific informed patient consent.
• Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation.
• Patient has primary diagnosis of non-inflammatory degenerative joint disease.
• Patient is a candidate for primary cementless total hip replacement.
• Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion Criteria:

• Patient has a Body Mass Index (BMI) > 40 Kg/m2.
• Patient has an active or suspected infection at the time of device implantation.
• Patient is immunologically suppressed.
• Patient requires revision surgery of a previously implanted total hip replacement.
• Patient has a known sensitivity to device materials.